Literature DB >> 24299690

Commentary in support of a highly effective hypertension treatment algorithm.

Joel Handler1.   

Abstract

A simple hypertension treatment algorithm has contributed to the achievement of control rates greater than 85% for more than 1 million adults with hypertension across the United States. It is built on the fixed-dose combination drug lisinopril/hydrochlorothiazide, which is maximized in three steps before adding amlodipine. Spironolactone is the preferred fourth drug. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24299690      PMCID： PMC8033930          DOI： 10.1111/jch.12182

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


  28 in total

1.  Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.

Authors:  John M Flack; Domenic A Sica; George Bakris; Angela L Brown; Keith C Ferdinand; Richard H Grimm; W Dallas Hall; Wendell E Jones; David S Kountz; Janice P Lea; Samar Nasser; Shawna D Nesbitt; Elijah Saunders; Margaret Scisney-Matlock; Kenneth A Jamerson
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

3.  Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Authors:  Jackson T Wright; J Kay Dunn; Jeffrey A Cutler; Barry R Davis; William C Cushman; Charles E Ford; L Julian Haywood; Frans H H Leenen; Karen L Margolis; Vasilios Papademetriou; Jeffrey L Probstfield; Paul K Whelton; Gabriel B Habib
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

Review 4.  Dosing frequency and medication adherence in chronic disease.

Authors:  Craig I Coleman; Brendan Limone; Diana M Sobieraj; Soyon Lee; Matthew S Roberts; Rajbir Kaur; Tawfikul Alam
Journal:  J Manag Care Pharm       Date:  2012-09

5.  Combination therapy in hypertension.

Authors:  Alan H Gradman; Jan N Basile; Barry L Carter; George L Bakris
Journal:  J Am Soc Hypertens       Date:  2010 Jan-Feb

6.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

7.  Effect of spironolactone on blood pressure in subjects with resistant hypertension.

Authors:  Neil Chapman; Joanna Dobson; Sarah Wilson; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Journal:  Hypertension       Date:  2007-02-19       Impact factor: 10.190

8.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Commentary in support of a highly effective hypertension treatment algorithm.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-07       Impact factor: 3.738
View more
  4 in total

1.  Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors.

Authors:  Thomas R Frieden; Marc G Jaffe
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

2.  Measure accurately, Act rapidly, and Partner with patients: An intuitive and practical three-part framework to guide efforts to improve hypertension control.

Authors:  Romsai T Boonyasai; Michael K Rakotz; Lisa H Lubomski; Donna M Daniel; Jill A Marsteller; Kathryn S Taylor; Lisa A Cooper; Omar Hasan; Matthew K Wynia
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-23       Impact factor: 3.738

3.  Commentary in support of a highly effective hypertension treatment algorithm.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-07       Impact factor: 3.738

4.  The evolving clinical management of hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.